October 15, 2015 / 12:41 PM / in 2 years

BUZZ-Transition Therapeutics Inc: Alzheimer drug effective in sub-group

** Canadian drug developer’s shares up nearly 17 pct premarket

** Company says analysis shows the drug ELND005 was effective in reducing severe agitation and aggression in Alzheimer’s patients

** Large study in June failed to hit main goal of reducing moderate to severe agitation and aggression in patients, pushing shares down as much as 20 pct that day

** Company says to discuss potential late-stage study with the U.S. FDA

** Up to Wednesday’s close, stock had fallen about 20 pct since the company reported top-line data from the study

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below